Clinical Trial: A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia

U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07061288) titled 'A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia' on July 02.

Brief Summary: The purpose of this study is to evaluate the dose levels, safety, and drug levels of KarXT intramuscular injection in participants with Schizophrenia

Study Start Date: Sept. 12

Study Type: INTERVENTIONAL

Condition: Schizophrenia

Intervention: DRUG: KarXT

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Squibb

Published by HT Digital Content Services with permission from Health Daily Digest....